sameAs
Host range and emerging and reemerging pathogensComparative evidence for a link between Peyer's patch development and susceptibility to transmissible spongiform encephalopathies.Global disease burden due to antibiotic resistance - state of the evidenceAssessing the Epidemic Potential of RNA and DNA VirusesSignatures of positive selection in East African Shorthorn Zebu: A genome-wide single nucleotide polymorphism analysisAntimicrobial resistance in humans, livestock and the wider environmentHuman schistosomiasis in the post mass drug administration era.Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09Rapid detection of pandemic influenza in the presence of seasonal influenza.Origin and fate of A/H1N1 influenza in Scotland during 2009Prediction and prevention of the next pandemic zoonosis.Human viruses: discovery and emergence.Effect of data quality on estimates of farm infectiousness trends in the UK 2001 foot-and-mouth disease epidemicEcological origins of novel human pathogens.Herd-level risk factors associated with the presence of Phage type 21/28 E. coli O157 on Scottish cattle farmsQuantification of Peyer's patches in Cheviot sheep for future scrapie pathogenesis studies.Geographic and topographic determinants of local FMD transmission applied to the 2001 UK FMD epidemic.Temporal and spatial patterns of bovine Escherichia coli O157 prevalence and comparison of temporal changes in the patterns of phage types associated with bovine shedding and human E. coli O157 cases in Scotland between 1998-2000 and 2002-2004.Effect of the initial dose of foot-and-mouth disease virus on the early viral dynamics within pigs.Signatures of Selection for Environmental Adaptation and Zebu × Taurine Hybrid Fitness in East African Shorthorn ZebuHow to make predictions about future infectious disease risks.Risk-targeted selection of agricultural holdings for post-epidemic surveillance: estimation of efficiency gains.Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis.Modelling Marek's disease virus (MDV) infection: parameter estimates for mortality rate and infectiousnessWhat is antibiotic resistance and how can we measure it?Lysogeny with Shiga toxin 2-encoding bacteriophages represses type III secretion in enterohemorrhagic Escherichia coli.Policy: An intergovernmental panel on antimicrobial resistance.Novel porcine-like human G26P[19] rotavirus identified in hospitalized paediatric diarrhoea patients in Ho Chi Minh City, Vietnam.Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmesSuper-shedding and the link between human infection and livestock carriage of Escherichia coli O157.Population biology of emerging and re-emerging pathogens.Design and descriptive epidemiology of the Infectious Diseases of East African Livestock (IDEAL) project, a longitudinal calf cohort study in western KenyaMortality in East African shorthorn zebu cattle under one year: predictors of infectious-disease mortalityGenetic susceptibility to infectious disease in East African Shorthorn Zebu: a genome-wide analysis of the effect of heterozygosity and exotic introgression.Parasite co-infections and their impact on survival of indigenous cattleA Meta-Analysis of Experimental Studies of Attenuated Schistosoma mansoni Vaccines in the Mouse Model.Suboptimal herd performance amplifies the spread of infectious disease in the cattle industry.Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children.Risk factors for the presence of high-level shedders of Escherichia coli O157 on Scottish farmsPathogenic potential to humans of bovine Escherichia coli O26, Scotland.
P50
Q24273386-42B25019-1069-4994-A249-786C947F604DQ25255274-AC0C6BD4-8244-4C7F-80F3-989AA33E0FA5Q26746731-12E82A07-CCE1-4148-8498-80F272769DCAQ27653821-C80CF055-5F24-4960-8335-909BFF3CF181Q28647751-FE1E0836-E26F-48DE-99D3-CD021DE36F4DQ28647857-E7126DCD-D946-49CB-B028-F85CAEDECCDFQ30240038-A41B2409-FF9E-47A1-9C09-B62E83A1D764Q30394336-7F42FDC2-C76F-4AEA-BFA1-E3B042072043Q30396665-28A59251-B0B5-4508-ABE8-A7AFFC63C608Q30413124-B0337A82-9BC7-4E55-9011-27E0BF2813C6Q30424289-7E33A412-72E0-4B5A-A8E6-139009F5B0D7Q30564146-F058BB52-822D-4660-813C-60E20916DC92Q31095774-53C97F66-8C6F-485C-AB2C-5125D10E1D6AQ31137471-ADB2074B-0AFC-47E7-B297-033BE28518E8Q33265239-89E8CFB1-5064-4738-A033-B4FAA8DCF589Q33275397-2ED285C6-C7FA-4348-ADA2-DA4BEBB7DB22Q33373820-EB94F8CB-00EA-4C21-8AD3-D7AEDB434EEDQ33521123-FCB09B31-5111-4365-850D-603F1300FAACQ33726687-3AAA1C36-D288-4246-9DFB-2620AB040EB1Q33774661-0B6044D9-BDDC-4181-97B3-B5367FF633E0Q33916044-6677B203-FFCD-4B0B-82F6-1DE1378F3B2BQ33932998-D63D32EB-33B5-4A23-A2C1-A82828C0FF73Q34058073-F7725212-E633-4262-AC1B-675EBEC78D00Q34073274-A8CAF436-816F-4060-B840-B6C4DF5342F3Q34104249-F3AF8B58-7298-4852-8A87-5EDD2597E555Q34276994-1F2895D6-9EC2-497B-92F2-F7A34EFE84F0Q34422023-83DA3921-BA54-4571-9D3F-ADBD71559EE2Q34520585-AC8AA6FA-BC34-4C8F-AF4E-D42C69F6189DQ34629346-5A60AF0D-6074-4937-ABB1-0EE499892E92Q34880314-64DAF990-A376-4EE2-B686-90234ED9B3C9Q34960265-AECFC9E2-6753-473F-B2A5-8ADAB0E1EB9FQ34977562-8BBF4A16-E784-442C-8552-6724881A10FEQ34980047-0EDC7B81-6CE2-4532-B4DC-982999F9C875Q35037582-EA75D0C0-EA35-4C4C-B154-215ABE788AF3Q35105801-9F1B4045-3BB9-4060-9A5D-E6BE20DDABBFQ35128551-41AED9CD-6D03-46D8-B742-67B6703D4566Q35132232-41F9B487-7D5B-4277-B4FE-925F1885744EQ35202035-EB4E4B16-5B6A-4CDC-9795-093609586CAFQ35784585-7DFFE101-342F-4069-BD01-088D809D98D0Q35844593-3C436643-9437-4192-8565-B03787E6C400
P50
description
British epidemiologist
@en
wetenschapper
@nl
name
Mark E.J. Woolhouse
@ast
Mark E.J. Woolhouse
@nl
Mark Woolhouse
@cs
Mark Woolhouse
@de
Mark Woolhouse
@en
Mark Woolhouse
@es
Mark Woolhouse
@fr
Mark Woolhouse
@pt
Mark Woolhouse
@sk
type
label
Mark E.J. Woolhouse
@ast
Mark E.J. Woolhouse
@nl
Mark Woolhouse
@cs
Mark Woolhouse
@de
Mark Woolhouse
@en
Mark Woolhouse
@es
Mark Woolhouse
@fr
Mark Woolhouse
@pt
Mark Woolhouse
@sk
altLabel
Mark E.J. Woolhouse
@en
Mark Edward John Woolhouse
@en
Mark Woolhouse
@en
Mark Woolhouse
@es
prefLabel
Mark E.J. Woolhouse
@ast
Mark E.J. Woolhouse
@nl
Mark Woolhouse
@cs
Mark Woolhouse
@de
Mark Woolhouse
@en
Mark Woolhouse
@es
Mark Woolhouse
@fr
Mark Woolhouse
@pt
Mark Woolhouse
@sk
P106
P21
P31
P496
0000-0003-3765-8167
P569
1959-01-01T00:00:00Z